Anthony Quinn - Insider Trading Tracker

卡萊多生物科學公司

US ˙ OTCPK ˙ US4833471000

簡介

本頁面提供了有關 Anthony Quinn 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言，基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是，他們必須透過Form 4向美國證券交易委員會（SEC）報告所有交易。盡管存在這些限制，學術研究表明，內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易，排除了作為10b5-1交易計劃的一部分的交易。然後，對每筆交易在3、6和12個月的表現進行平均，以生成該筆交易最終的表現指標。最終，將所有交易的表現指標進行平均，計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A"，則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易，或者他們進行的交易距離現在太近，無法計算出可靠的表現指標。

更新頻率：每日

查看收益最高的的內幕交易者列表。

查看排名最高的內部人士。

報告內部持倉的公司

SEC文件顯示Anthony Quinn已報告在以下公司擁有持倉或進行了交易：

證券	職位	最新報告的持倉
US:GBIO / Generation Bio Co.	Director	0
US:AGLE / Aeglea BioTherapeutics Inc	President & CEO, Director	550,540
US:KLDO / Kaleido Biosciences, Inc.	Director	15,000
US:GEVA / Synageva Biopharma Corp	EVP, CMO, & Head of R&D	0

如何解讀這些圖表

以下圖表顯示了在Anthony Quinn進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如，如果一筆內部人士交易是在2019年1月1日進行的，該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元，則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%，而從10美元跌至5美元的價格變化將為-50%。

最終，我們將評估內部人士的交易與股價的超額回報（正向或負向）之間的相關性，以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為，我們預期看到（a）購買後的正回報，或者（b）賣出後的負回報。對於情況（a），購買圖表將顯示一系列向上傾斜的曲線，表示每次購買後都有正回報。對於情況（b），賣出圖表將顯示一系列向下傾斜的曲線，表示每次賣出後都有負回報。

然而，僅憑這一點還不足以得出結論。例如，如果公司的股價在多年內呈現非周期性上升，我們會預期所有購買後的圖表都呈現向上傾斜。同樣地，多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下，「購買」圖表顯示正向信號，而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易，以獲得財務優勢。

KLDO / Kaleido Biosciences, Inc.內部人士買入 - 短期收益分析

在這一部分，我們分析了在 KLDO / Kaleido Biosciences, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報，以及是否值得跟踪。該分析基於每筆交易後一年的情況，結果僅為理論值。

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

KLDO / Kaleido Biosciences, Inc. Insider Trades

KLDO / Kaleido Biosciences, Inc.內部人士賣出 - 短期虧損分析

在這一部分，我們分析了在 KLDO / Kaleido Biosciences, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式，可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況，

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SYRE / Spyre Therapeutics, Inc.內部人士買入 - 短期收益分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最高利潤的天數	達到最高利潤時的價格	最高淨利 ($)	最高回報率（%）
2022-03-16	AGLE	Quinn Anthony	80,079	2.3440	3,203	58.6000	187,705	2	68	30,099	16.04
2022-03-15	AGLE	Quinn Anthony	42,417	1.8611	1,697	46.5275	78,942
2022-03-14	AGLE	Quinn Anthony	67,472	1.9300	2,699	48.2500	130,221
2022-03-11	AGLE	Quinn Anthony	34,777	2.0640	1,391	51.6000	71,780
2021-12-10	AGLE	Quinn Anthony	10,526	3.7500	421	93.7500	39,472
2021-12-09	AGLE	Quinn Anthony	43,108	3.7000	1,724	92.5000	159,500
2020-04-30	AGLE	Quinn Anthony	165,000	4.7500	6,600	118.7500	783,750
2019-06-14	AGLE	Quinn Anthony	5,282	6.2311	211	155.7775	32,913
2019-06-13	AGLE	Quinn Anthony	14,406	6.1666	576	154.1650	88,836
2019-06-12	AGLE	Quinn Anthony	12,217	6.1148	489	152.8700	74,705
2019-05-22	AGLE	Quinn Anthony	3,809	6.8596	152	171.4900	26,128
2019-05-21	AGLE	Quinn Anthony	13,794	6.8857	552	172.1425	94,981
2019-05-20	AGLE	Quinn Anthony	8,989	6.5550	360	163.8750	58,923
2019-05-17	AGLE	Quinn Anthony	6,218	6.6477	249	166.1925	41,335
2019-05-16	AGLE	Quinn Anthony	5,520	6.8280	221	170.7000	37,691
2019-05-15	AGLE	Quinn Anthony	6,256	6.7566	250	168.9150	42,269
2019-02-15	AGLE	Quinn Anthony	719	7.0980	29	177.4500	5,103
2018-08-15	AGLE	Quinn Anthony	994	9.1300	40	228.2500	9,075
2018-02-15	AGLE	Quinn Anthony	2,000	6.0200	80	150.5000	12,040
2017-12-08	AGLE	Quinn Anthony	600	5.0650	24	126.6250	3,039
2017-12-07	AGLE	Quinn Anthony	2,800	4.9882	112	124.7050	13,967
2017-12-06	AGLE	Quinn Anthony	4,888	4.9248	196	123.1200	24,072
2017-12-05	AGLE	Quinn Anthony	5,065	4.9310	203	123.2750	24,976
2017-12-04	AGLE	Quinn Anthony	7,956	4.9804	318	124.5100	39,624
2017-12-01	AGLE	Quinn Anthony	4,100	4.5312	164	113.2800	18,578
2016-04-12	AGLE	Quinn Anthony	10,000	10.0000	400	250.0000	100,000

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

SYRE / Spyre Therapeutics, Inc. Insider Trades

SYRE / Spyre Therapeutics, Inc.內部人士賣出 - 短期虧損分析

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期	證券代碼	內部人士	報告股數	Reported 價格	經調整股數	經調整價格	成本基礎	達到最低利潤的天數	達到最低利潤時的價格	避免的最高損失金額($)	避免的最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

歷史內部人交易

該表格顯示了由 Anthony Quinn 進行的所有內幕交易的完整列表，這些交易已向美國證券交易委員會（SEC）披露。

呈報日期	交易日期	表格	證券代碼	證券	代碼	10b5-1	股份	剩餘股份	% 變化	每股股價	交易金額	剩餘金額
2026-02-09	2026-02-09	4	GBIO	Generation Bio Co. Common Stock	U - Other		-7,283	0	-100.00
2026-02-09	2026-02-09	4	GBIO	Generation Bio Co. Common Stock	U - Other		-29,928	0	-100.00
2025-01-14	2025-01-13	4	GBIO	Generation Bio Co. Common Stock	P - Purchase		85,000	299,286	39.67	0.97	82,450	290,307
2025-01-14	2025-01-10	4	GBIO	Generation Bio Co. Common Stock	P - Purchase		125,791	214,286	142.14	0.96	120,759	205,715
2023-12-05	2023-12-01	4	GBIO	Generation Bio Co. Common Stock	P - Purchase		88,495	88,495		1.41	124,778	124,778
2022-03-18	2022-03-16	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		80,079	550,540	17.02	2.34	187,705	1,290,466
2022-03-15	2022-03-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		42,417	473,461	9.84	1.86	78,942	881,158
2022-03-15	2022-03-14	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		67,472	431,044	18.56	1.93	130,221	831,915
2022-03-15	2022-03-11	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		34,777	363,572	10.58	2.06	71,780	750,413
2022-02-22	2022-02-17	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		350,000	350,000
2022-02-14	2021-10-20	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		10,000	208,845	5.03
2022-02-14	2021-10-20	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		-10,000	328,795	-2.95
2022-02-14	2021-10-18	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		23,809	208,845	12.87
2022-02-14	2021-10-18	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		-23,809	328,795	-6.75
2022-02-14	2021-10-14	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		175,036	208,845	517.72
2022-02-14	2021-10-14	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		-175,036	328,795	-34.74
2022-02-14	2018-12-28	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		57,450	57,450
2022-02-14	2018-12-28	5	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	G - Gift		-57,450	328,795	-14.87
2021-12-13	2021-12-10	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		10,526	328,795	3.31	3.75	39,472	1,232,981
2021-12-13	2021-12-09	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		43,108	318,269	15.67	3.70	159,500	1,177,595
2021-10-29	2021-10-28	4	GBIO	Generation Bio Co. Common Stock	G - Gift		72,837	72,837
2021-10-29	2021-10-28	4	GBIO	Generation Bio Co. Common Stock	G - Gift		-72,837	0	-100.00
2021-07-01	2021-06-30	4	KLDO	Kaleido Biosciences, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2021-06-11	2021-06-09	4	GBIO	Generation Bio Co. Stock Option (right to buy)	A - Award		15,000	15,000
2021-02-19	2021-02-17	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		330,000	330,000
2020-07-01	2020-06-30	4	KLDO	Kaleido Biosciences, Inc. Stock Option (Right to Buy)	A - Award		15,000	15,000
2020-06-18	2020-06-16	4	GBIO	Generation Bio Co. Series C Preferred Stock	C - Conversion		-53,654	0	-100.00
2020-06-18	2020-06-16	4	GBIO	Generation Bio Co. Common Stock	C - Conversion		30,376	72,837	71.54
2020-06-15	2020-06-11	4	GBIO	Generation Bio Co. Stock Option (right to buy)	A - Award		52,000	52,000
2020-06-11		3	GBIO	Generation Bio Co. Common Stock				84,922
2020-06-11		3	GBIO	Generation Bio Co. Common Stock				84,922
2020-06-11		3	GBIO	Generation Bio Co. Common Stock				84,922
2020-05-04	2020-04-30	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		165,000	538,469	44.18	4.75	783,750	2,557,728
2020-02-19	2020-02-14	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		301,000	301,000
2019-10-07	2019-10-04	4	AGLE	Aeglea BioTherapeutics, Inc. Stock Option (right to buy)	M - Exercise		-17,603	119,914	-12.80
2019-10-07	2019-10-04	4	AGLE	Aeglea BioTherapeutics, Inc. Stock Option (right to buy)	M - Exercise		-662	0	-100.00
2019-10-07	2019-10-04	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		17,603	371,908	4.97	6.31	111,075	2,346,739
2019-10-07	2019-10-04	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		662	354,305	0.19	5.46	3,615	1,934,505
2019-06-14	2019-06-14	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		5,282	353,643	1.52	6.23	32,913	2,203,585
2019-06-14	2019-06-13	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		14,406	348,361	4.31	6.17	88,836	2,148,203
2019-06-14	2019-06-12	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		12,217	333,955	3.80	6.11	74,705	2,042,068
2019-05-22	2019-05-22	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		3,809	321,738	1.20	6.86	26,128	2,206,994
2019-05-22	2019-05-21	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		13,794	317,929	4.54	6.89	94,981	2,189,164
2019-05-22	2019-05-20	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		8,989	304,135	3.05	6.56	58,923	1,993,605
2019-05-17	2019-05-17	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		6,218	295,146	2.15	6.65	41,335	1,962,042
2019-05-17	2019-05-16	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		5,520	288,928	1.95	6.83	37,691	1,972,800
2019-05-17	2019-05-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		6,256	283,408	2.26	6.76	42,269	1,914,874
2019-05-17	2019-02-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		719	277,152	0.26	7.10	5,103	1,967,225
2019-03-04	2019-03-04	4	KLDO	Kaleido Biosciences, Inc. Series B Preferred Stock	C - Conversion		-25,707	0	-100.00
2019-03-04	2019-03-04	4	KLDO	Kaleido Biosciences, Inc. Common Stock	C - Conversion		12,853	31,603	68.55
2019-03-01	2019-02-28	4	AGLE	Aeglea BioTherapeutics, Inc. Stock Option (right to buy)	A - Award		280,000	280,000
2019-02-27		3	KLDO	Kaleido Biosciences, Inc. Common Stock				37,500
2019-02-27		3	KLDO	Kaleido Biosciences, Inc. Common Stock				37,500
2019-02-27		3	KLDO	Kaleido Biosciences, Inc. Common Stock				37,500
2019-02-08	2019-02-06	4	AGLE	Aeglea BioTherapeutics, Inc. Stock Option (right to buy)	M - Exercise		-7,433	137,517	-5.13
2019-02-08	2019-02-06	4	AGLE	Aeglea BioTherapeutics, Inc. Stock Option (right to buy)	M - Exercise		-1,323	662	-66.65
2019-02-08	2019-02-06	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		7,433	276,433	2.76	6.31	46,902	1,744,292
2019-02-08	2019-02-06	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		1,323	269,000	0.49	5.46	7,224	1,468,740
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-18,584	144,950	-11.36
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-3,306	1,985	-62.48
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-150,000	0	-100.00
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		18,584	267,677	7.46	6.31	117,265	1,689,042
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		3,306	249,093	1.35	5.46	18,051	1,360,048
2018-12-10	2018-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		150,000	245,787	156.60	4.11	616,500	1,010,185
2018-12-10	2018-08-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		994	95,787	1.05	9.13	9,075	874,535
2018-12-10	2018-02-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		2,000	94,793	2.16	6.02	12,040	570,654
2018-07-20	2018-07-18	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		50,000	50,000
2018-07-20	2018-07-18	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		75,000	75,000
2018-07-20	2018-07-18	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		75,000	75,000
2018-07-20	2018-07-18	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		300,000	300,000
2018-07-16	2018-07-12	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-14,866	163,534	-8.33
2018-07-16	2018-07-12	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-24,000	0	-100.00
2018-07-16	2018-07-12	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		14,866	92,793	19.08	6.31	93,804	585,524
2018-07-16	2018-07-12	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		24,000	77,927	44.50	7.04	168,960	548,606
2018-07-13	2018-07-11	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-3,307	5,291	-38.46
2018-07-13	2018-07-11	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		3,307	53,927	6.53	5.46	18,056	294,441
2018-02-22	2018-02-20	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		178,400	178,400
2018-02-20	2018-02-15	4	AGLE	Aeglea BioTherapeutics, Inc. Director Stock Option (right to buy)	M - Exercise		-15,211	8,598	-63.89
2018-02-20	2018-02-15	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	M - Exercise		15,211	50,620	42.96	5.46	83,052	276,385
2017-12-08	2017-12-08	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		600	35,409	1.72	5.06	3,039	179,347
2017-12-08	2017-12-07	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		2,800	34,809	8.75	4.99	13,967	173,634
2017-12-08	2017-12-06	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		4,888	32,009	18.02	4.92	24,072	157,638
2017-12-05	2017-12-05	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		5,065	27,121	22.96	4.93	24,976	133,734
2017-12-05	2017-12-04	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		7,956	22,056	56.43	4.98	39,624	109,848
2017-12-05	2017-12-01	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		4,100	14,100	41.00	4.53	18,578	63,890
2017-09-01	2017-08-31	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		150,000	150,000
2017-04-25	2017-04-21	4	AGLE	Aeglea BioTherapeutics, Inc. Employee Stock Option (right to buy)	A - Award		24,000	24,000
2016-04-12	2016-04-12	4	AGLE	Aeglea BioTherapeutics, Inc. Common Stock	P - Purchase		10,000	10,000		10.00	100,000	100,000
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-45,000	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-45,000	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-35,000	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-20,497	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-37,228	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-5,982	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Options (Right to Buy)	D - Sale to Issuer		-8,964	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	D - Sale to Issuer		-27,000	0	-100.00
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	D - Sale to Issuer		-5,675	27,000	-17.37
2015-06-23	2015-06-22	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		38	32,675	0.12	78.87	2,997	2,577,077
2015-06-09	2015-06-05	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		27,000	32,637	478.98
2015-04-29	2015-04-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	37,228	-21.17
2015-04-29	2015-04-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-10,000	5,637	-63.95	110.00	-1,100,000	620,070
2015-04-29	2015-04-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	15,637	177.40	1.70	17,000	26,583
2015-04-23	2015-04-21	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-10,000	5,637	-63.95	108.00	-1,080,000	608,796
2015-04-17	2015-04-15	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	35,000	-22.22
2015-04-17	2015-04-15	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-10,000	15,637	-39.01	105.00	-1,050,000	1,641,885
2015-04-17	2015-04-15	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	25,637	63.95	40.74	407,400	1,044,451
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-9,503	20,497	-31.68
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	8,964	-52.73
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-29,503	15,637	-65.36	93.76	-2,766,201	1,466,125
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	9,503	45,140	26.67	23.00	218,569	1,038,220
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	35,637	39.01	0.95	9,500	33,855
2015-04-08	2015-04-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		42	25,637	0.16	76.88	3,229	1,970,973
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	30,000	-25.00
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-300	25,595	-1.16	72.88	-21,864	1,865,364
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-700	25,895	-2.63	71.96	-50,372	1,863,404
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-400	26,595	-1.48	70.50	-28,200	1,874,948
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-8,600	26,995	-24.16	69.88	-600,968	1,886,411
2014-09-04	2014-09-02	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	35,595	39.07	23.00	230,000	818,685
2014-07-02	2014-06-30	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		71	25,595	0.28	54.89	3,897	1,404,910
2014-06-05	2014-06-04	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	A - Award		45,000	45,000
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	18,964	-34.53
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	25,524	64.42	0.95	9,500	24,248
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	40,000	-20.00
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-10,000	40,000	-20.00
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-1,050	15,524	-6.34	85.76	-90,048	1,331,338
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-4,746	16,574	-22.26	84.72	-402,081	1,404,149
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-3,529	21,320	-14.20	83.50	-294,672	1,780,220
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-10,675	24,849	-30.05	82.80	-883,890	2,057,497
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	35,524	39.18	23.00	230,000	817,052
2014-04-03	2014-04-01	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	10,000	25,524	64.42	0.95	9,500	24,248
2014-01-02	2013-12-31	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		192	15,524	1.25	36.30	6,970	563,521
2013-07-01	2013-06-28	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	A - Award		297	15,332	1.98	35.68	10,597	547,046
2013-06-10	2013-06-06	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	A - Award		45,000	45,000
2013-01-23	2013-01-18	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-9,447	38,964	-19.51
2013-01-23	2013-01-18	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-9,447	15,035	-38.59	50.08	-473,106	752,953
2013-01-23	2013-01-18	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	9,447	24,482	62.83	0.95	8,975	23,258
2013-01-18	2013-01-17	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-200	48,411	-0.41
2013-01-18	2013-01-17	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-200	15,035	-1.31	50.00	-10,000	751,750
2013-01-18	2013-01-17	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	200	15,235	1.33	0.95	190	14,473
2013-01-18	2013-01-16	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-353	48,611	-0.72
2013-01-18	2013-01-16	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-5,353	15,035	-26.26	50.07	-268,025	752,802
2013-01-18	2013-01-16	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	353	20,388	1.76	0.95	335	19,369
2012-07-30	2012-07-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-6,400	48,964	-11.56
2012-07-30	2012-07-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-6,400	20,035	-24.21	50.23	-321,501	1,006,450
2012-07-30	2012-07-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	6,400	26,435	31.94	0.95	6,080	25,113
2012-07-30	2012-07-26	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-1,100	55,364	-1.95
2012-07-30	2012-07-26	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-1,100	20,035	-5.20	50.00	-55,000	1,001,750
2012-07-30	2012-07-26	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	1,100	21,135	5.49	0.95	1,045	20,078
2012-07-23	2012-07-20	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-600	56,464	-1.05
2012-07-23	2012-07-20	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-600	20,035	-2.91	50.00	-30,000	1,001,750
2012-07-23	2012-07-20	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	600	20,635	2.99	0.95	570	19,603
2012-07-23	2012-07-19	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	M - Exercise	X	-1,900	57,064	-3.22
2012-07-23	2012-07-19	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-1,900	20,035	-8.66	50.00	-95,000	1,001,750
2012-07-23	2012-07-19	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	M - Exercise	X	1,900	21,935	9.48	0.95	1,805	20,838
2012-06-29	2012-06-27	4	GEVA	SYNAGEVA BIOPHARMA CORP Stock Option (Right to Buy)	A - Award		45,000	45,000
2012-06-27	2012-06-25	4	GEVA	SYNAGEVA BIOPHARMA CORP Common Stock	S - Sale	X	-26,000	20,035	-56.48	40.65	-1,056,874	814,403

非衍生或衍生證券的公開市場或私下買入

非衍生或衍生證券的公開市場或私下賣出

公司向內部人員授予、獎勵或以其他方式獲取證券（例如股票期權）

衍生工具轉換

將證券賣出或轉讓回公司

使用從公司收到的證券的一部分來支付行使價或稅務負擔。

內部人士贈送或接收他人贈送公司股票

股權掉期和類似的避險交易

行使或轉換從公司獲得的衍生證券（例如期權）

內部人士透過Form 4自願報告的一筆交易

其他（附有交易描述的腳註）